Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan in Recurrent Carcinosarcoma of the Uterus
NCT00003156Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Jun 1998
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of topotecan in uterine carcinosarcoma (UCS), sponsored by GOG Foundation. Started Jun 1998; status: terminated.
02
Drugs
topotecan
03
Conditions
uterine carcinosarcoma (UCS)
Beyond the preview
Go deeper on NCT00003156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003156.